Zacks: Analysts Expect Nu Skin Enterprises, Inc. (NUS) Will Post Quarterly Sales of $644.01 Million

Analysts expect that Nu Skin Enterprises, Inc. (NYSE:NUS) will post $644.01 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Nu Skin Enterprises’ earnings. The lowest sales estimate is $643.74 million and the highest is $644.27 million. Nu Skin Enterprises posted sales of $550.10 million in the same quarter last year, which suggests a positive year over year growth rate of 17.1%. The firm is scheduled to report its next quarterly earnings report on Wednesday, August 1st.

On average, analysts expect that Nu Skin Enterprises will report full year sales of $2.54 billion for the current financial year, with estimates ranging from $2.53 billion to $2.55 billion. For the next fiscal year, analysts anticipate that the business will post sales of $2.61 billion per share, with estimates ranging from $2.59 billion to $2.62 billion. Zacks’ sales calculations are a mean average based on a survey of research firms that that provide coverage for Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, April 26th. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.09. The company had revenue of $616.00 million for the quarter, compared to analyst estimates of $564.46 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.36%. Nu Skin Enterprises’s revenue was up 23.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.51 EPS.

Several equities analysts have weighed in on the stock. Citigroup boosted their target price on shares of Nu Skin Enterprises from $81.00 to $82.00 and gave the company a “buy” rating in a report on Monday, April 30th. Jefferies Financial Group assumed coverage on shares of Nu Skin Enterprises in a report on Thursday. They issued a “buy” rating and a $98.00 target price on the stock. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Tuesday. Pivotal Research reiterated a “buy” rating and issued a $90.00 target price on shares of Nu Skin Enterprises in a report on Friday, February 16th. Finally, ValuEngine lowered shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 6th. Three analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company’s stock. Nu Skin Enterprises presently has a consensus rating of “Hold” and an average target price of $77.00.

In related news, General Counsel D Matthew Dorny sold 3,250 shares of the company’s stock in a transaction that occurred on Monday, April 2nd. The shares were sold at an average price of $72.22, for a total transaction of $234,715.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Chairman Steven Lund sold 81,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 4th. The stock was sold at an average price of $75.00, for a total transaction of $6,075,000.00. Following the sale, the chairman now directly owns 4,769 shares in the company, valued at $357,675. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 109,750 shares of company stock worth $8,259,910. 3.00% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Allianz Asset Management GmbH purchased a new stake in shares of Nu Skin Enterprises in the 1st quarter valued at approximately $293,000. Principal Financial Group Inc. increased its position in shares of Nu Skin Enterprises by 2.3% in the 1st quarter. Principal Financial Group Inc. now owns 217,221 shares of the company’s stock valued at $16,011,000 after purchasing an additional 4,781 shares during the last quarter. WINTON GROUP Ltd purchased a new stake in shares of Nu Skin Enterprises in the 1st quarter valued at approximately $740,000. CIBC World Markets Inc. purchased a new stake in shares of Nu Skin Enterprises in the 1st quarter valued at approximately $1,228,000. Finally, Xact Kapitalforvaltning AB increased its position in shares of Nu Skin Enterprises by 58.6% in the 1st quarter. Xact Kapitalforvaltning AB now owns 8,116 shares of the company’s stock valued at $598,000 after purchasing an additional 3,000 shares during the last quarter. 76.89% of the stock is currently owned by hedge funds and other institutional investors.

Nu Skin Enterprises traded up $1.55, hitting $83.53, on Monday, Marketbeat reports. The stock had a trading volume of 530,599 shares, compared to its average volume of 514,187. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.14 and a quick ratio of 0.75. The firm has a market capitalization of $4.51 billion, a price-to-earnings ratio of 25.89, a PEG ratio of 2.74 and a beta of 1.34. Nu Skin Enterprises has a 1-year low of $53.50 and a 1-year high of $84.00.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 13th. Investors of record on Friday, May 25th were paid a dividend of $0.365 per share. This represents a $1.46 annualized dividend and a yield of 1.75%. The ex-dividend date was Thursday, May 24th. Nu Skin Enterprises’s payout ratio is currently 45.20%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply